It was shown that GRP78 promotes EMT in head and neck cancer cells [214], colon cancer cells [215], lung cancer cells [216,217,218,219], breast cancer cells [220,221], nasopharyngeal carcinoma cells [222], prostate cancer, and multiple myeloma cells [223]. This evidence concerns the gene HSPA5 and colonic neoplasm.